
Biomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.
Supplements and Featured Publications
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Treatment Options for Rheumatoid Arthritisabout 27 years ago
The Burden of Rheumatoid Arthritisabout 27 years ago
Managed Care Issues and Rheumatoid Arthritis Treatmentabout 27 years ago
Faculty Question-and-Answer Sessionabout 27 years ago
Roundtable I: Practice Patterns for Treating Rheumatoid Arthritisabout 27 years ago
Roundtable II: Cost Concerns for Rheumatoid Arthritis Treatmentabout 27 years ago
Selected Abstracts





